3,4-dihydroxyphenylacetic acid has been researched along with buthionine sulfoximine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Andersen, JK; Hamill, RW; Harnish, P; Hom, DG; Lee, FY; McNeill, TH; Mo, JQ | 1 |
Casarejos, MJ; Correa, C; García de Yébenes, J; Mena, MA; Menéndez, J; Rodríguez-Navarro, JA; Solano, RM | 1 |
4 other study(ies) available for 3,4-dihydroxyphenylacetic acid and buthionine sulfoximine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Buthionine Sulfoximine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Glutathione; Homovanillic Acid; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neurons; Substantia Nigra; Tyrosine 3-Monooxygenase | 1996 |
Differential effects of l-DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal-enriched cultures from parkin knockout and wild-type mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antimetabolites; Antiparkinson Agents; Apoptosis; Biogenic Monoamines; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Dopamine; Embryo, Mammalian; Glutathione; Levodopa; MAP Kinase Signaling System; Mesencephalon; Mice; Mice, Knockout; Neurons; Phosphatidylinositol 3-Kinases; Signal Transduction; Ubiquitin-Protein Ligases | 2005 |